Dewey Steadman | Head, IR |
Dr. Martine Rothblatt | Chairperson, CEO |
Michael Benkowitz | President, COO |
Dr. Leigh Peterson | SVP, Product Development |
Pat Poisson | EVP, Technical Operations |
Hartaj Singh | Oppenheimer & Co |
Eun Yang | Jefferies |
Joe Thome | Cowen |
Jessica Fye | JPMorgan |
Andreas Argyrides | Wedbush Securities |
Good morning, and welcome to the United Therapeutics Corporation Second Quarter 2022 Earnings Webcast. My name is Dennis, and I will be your conference operator today. [Operator Instructions] I will now turn the webcast over to Dewey Steadman, Head of Investor Relations at United Therapeutics.
Good morning. Thank you, Dennis.